Engene Therapeutics (ENGN) traded down -1.27 % during a 24 hours period ending at 01:29 AM Central Europe on Tuesday 27th. One Engene Therapeutics stock can currently be bought for about USD 1.58 on popular exchanges. Current supply of Engene Therapeutics stocks is 67 mn. Engene Therapeutics has a current market capitalization of USD 104.6 mn and approximately USD 1.1 mn worth of Engene Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Engene Therapeutics has traded -18.75 % down. Simple moving average of last 200 days is at USD 4.54. The highest price of past 52 weeks was recorded at USD 12.25 on 01/23/2026. 52 weeks low was at USD 1.4 on 05/12/2026.
Here is how related stocks have performed in the past 24 hours:
Decisive (DE.V) traded down -1.01 % and now trades at CAD 7.75. Decisive has a market capitalisation of CAD 166.7 mn. Decisive has a current price to earnings ratio of 60.9.
Lotus Creek Exploration (LTC.V) traded up 0.93 % and now trades at CAD 4.36. Lotus Creek Exploration has a market capitalisation of CAD 175.4 mn.
Growth (AFN.TO) traded down -0.68 % and now trades at CAD 9. Current market capitalisation for Growth is CAD 165.4 mn.
Western Forest Products (WEF.TO) traded up 2.69 % and now trades at CAD 15.92. Current market capitalisation for Western Forest Products is CAD 165.3 mn.
Goldmoney (XAU.TO) traded flat 0 % and now trades at CAD 12.8. Goldmoney has a market capitalisation of CAD 166.5 mn. Goldmoney has a current price to earnings ratio of 2.88.
About Engene Therapeutics
Engene Holdings Inc. is a health care company based in Wilmington, United States, which is listed on the Nasdaq stock exchange.
